| Stage | NUE | % of rev | SXC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.4B | 100.00% | $486M | 100.00% | NUE ×21.40 |
| Gross profit | $2.0B | 19.56% | $486M | 100.00% | SXC +80.4pp |
| Operating income | $1.6B | 15.67% | $41M | 8.36% | NUE +7.3pp |
| Pre-tax income | $1.6B | 15.63% | $32M | 6.61% | NUE +9.0pp |
| Net income | $1.3B | 12.31% | $24M | 4.90% | NUE +7.4pp |
| Stage | NUE | SXC | Gap · A − B |
|---|---|---|---|
| Revenue | $10.4B100.00% | $486M100.00% | NUE ×21.40 |
| Gross profit | 19.56%$2.0B | 100.00%$486M | SXC +80.4pp |
| Operating income | 15.67%$1.6B | 8.36%$41M | NUE +7.3pp |
| Pre-tax income | 15.63%$1.6B | 6.61%$32M | NUE +9.0pp |
| Net income |
| 12.31%$1.3B |
| 4.90%$24M |
| NUE +7.4pp |
No shared counterparties.